Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Neuroreport
|
October 25, 2017
MrgprA3 shows sensitization to chloroquine in an acetone-ether-water mice model
Hao Shi, Guang Yu, Xiao Geng, et al.
Neural Plasticity
|
January 29, 2016
TRPV1 and PLC Participate in Histamine H4 Receptor-Induced Itch
Tunyu Jian, Niuniu Yang, Yan Yang, et al.
Brain Research
|
February 14, 2016
Voltage-gated potassium channels involved in regulation of physiological function in MrgprA3-specific itch neurons
Min Tang, Guanyi Wu, Zhongli Wang, et al.
Cell Calcium
|
June 4, 2021
Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4
Jinjin Yan, Fan Ye, Ying Ju, et al.
International Journal of Molecular Medicine
|
June 30, 2018
Characteristics of circular RNA expression in lung tissues from mice with hypoxia‑induced pulmonary hypertension
Jian Wang, Meng-Chan Zhu, Bill Kalionis, et al.
Neural Plasticity
|
July 26, 2017
A Combined Water Extract of Frankincense and Myrrh Alleviates Neuropathic Pain in Mice via Modulation of TRPV1
Danyou Hu, Changming Wang, Fengxian Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 19, 2024
Gastrodin alleviates NTG-induced migraine-like pain via inhibiting succinate/HIF-1α/TRPM2 signaling pathway in trigeminal ganglion
Chao Ma, Chunran Zhu, Yajun Zhang, et al.
British Journal of Pharmacology
|
November 24, 2024
S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis
Xinyu Zhang, Yuan Zhou, Changming Wang, et al.
Frontiers in Endocrinology
|
September 26, 2022
Relationship between physical performance and mild cognitive impairment in elderly hemodialysis patients is modified by the presence of diabetes: A multicenter cross-sectional study
Yinjiao Zhao, Peiyu Song, Chan Zhu, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial
Huizi Sha, Fan Tong, Jiayao Ni, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Neuroreport
|
October 25, 2017
MrgprA3 shows sensitization to chloroquine in an acetone-ether-water mice model
Hao Shi, Guang Yu, Xiao Geng, et al.
Neural Plasticity
|
January 29, 2016
TRPV1 and PLC Participate in Histamine H4 Receptor-Induced Itch
Tunyu Jian, Niuniu Yang, Yan Yang, et al.
Brain Research
|
February 14, 2016
Voltage-gated potassium channels involved in regulation of physiological function in MrgprA3-specific itch neurons
Min Tang, Guanyi Wu, Zhongli Wang, et al.
Cell Calcium
|
June 4, 2021
Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4
Jinjin Yan, Fan Ye, Ying Ju, et al.
International Journal of Molecular Medicine
|
June 30, 2018
Characteristics of circular RNA expression in lung tissues from mice with hypoxia‑induced pulmonary hypertension
Jian Wang, Meng-Chan Zhu, Bill Kalionis, et al.
Neural Plasticity
|
July 26, 2017
A Combined Water Extract of Frankincense and Myrrh Alleviates Neuropathic Pain in Mice via Modulation of TRPV1
Danyou Hu, Changming Wang, Fengxian Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 19, 2024
Gastrodin alleviates NTG-induced migraine-like pain via inhibiting succinate/HIF-1α/TRPM2 signaling pathway in trigeminal ganglion
Chao Ma, Chunran Zhu, Yajun Zhang, et al.
British Journal of Pharmacology
|
November 24, 2024
S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis
Xinyu Zhang, Yuan Zhou, Changming Wang, et al.
Frontiers in Endocrinology
|
September 26, 2022
Relationship between physical performance and mild cognitive impairment in elderly hemodialysis patients is modified by the presence of diabetes: A multicenter cross-sectional study
Yinjiao Zhao, Peiyu Song, Chan Zhu, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial
Huizi Sha, Fan Tong, Jiayao Ni, et al.
Page
of 10